Home › Funds › BOUSSARD & GAVAUDAN GESTION SAS › ANIP

BOUSSARD & GAVAUDAN GESTION SAS position in ANIP

ANI PHARMACEUTICALS INC · Health Care

BOUSSARD & GAVAUDAN GESTION SAS reported holding 5,800 shares of ANIP (ANI PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$6.8M, representing 0.81% of its reported portfolio and ranking #31 among its reported holdings. BOUSSARD & GAVAUDAN GESTION SAS has disclosed ANIP holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)5.80K sh
Reported value held$6.83M
Portfolio Weight0.81%
First reportedQ2 2026
Last changeReduce
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How BOUSSARD & GAVAUDAN GESTION SAS's ANIP position evolved

BOUSSARD & GAVAUDAN GESTION SAS first disclosed a stake in ANIP in Q2 2026 at 13,000 shares (US$17.1M). Across 2 filings, BOUSSARD & GAVAUDAN GESTION SAS increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 5,800 shares valued at US$6.8M — a reduction of -7,200 shares quarter over quarter.. Notable position changes include a 55% trim in Q3 2026 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 13.00K $17.07M New
Q3 2026 5.80K $6.83M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANIP and 13F data

ANIP (ANI PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in ANIP — the largest reported positions include Soleus Capital Management, L.P. (US$71.8M), TANG CAPITAL MANAGEMENT LLC (US$58.6M), Global Alpha Capital Management Ltd. (US$46.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANIP

All ANIP fund holders →

FAQ

How long has BOUSSARD & GAVAUDAN GESTION SAS held ANIP?

BOUSSARD & GAVAUDAN GESTION SAS has disclosed ANIP holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is BOUSSARD & GAVAUDAN GESTION SAS's current position in ANIP?

As of Q3 2026, BOUSSARD & GAVAUDAN GESTION SAS holds 5.80K shares of ANIP (ANI PHARMACEUTICALS INC), valued at $6.83M, representing 0.81% of its reported portfolio and ranking #31.

Has BOUSSARD & GAVAUDAN GESTION SAS been buying or selling ANIP?

In the latest 13F filing (Q3 2026), BOUSSARD & GAVAUDAN GESTION SAS reduced its position in ANIP.

Which other funds hold ANIP?

Other major institutional holders of ANIP include Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, Global Alpha Capital Management Ltd., among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.